Nundina › Khám phá lịch › Lịch Cuộc họp Hội đồng Tư vấn FDA › FDA advisory committee: Dermatologic and Ophthalmic Drugs Advisory Committee - New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%FDA advisory committee: Dermatologic and Ophthalmic Drugs Advisory Committee - New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%lúc 12:30 30 tháng 10, 2026 UTCPublic meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee, announced by the FDA in the Federal Register on 2026-09-25. Topic: New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%. Times are as stated in the notice (Eastern Time).Lịch Cuộc họp Hội đồng Tư vấn FDASự kiện khác của lịch này

lúc 14:00 19 tháng 11, 2026 UTC - FDA advisory committee: Microbiology Devices Panel of the Medical Devices Advisory Committee - Pathogen-Agnostic Sequencing